Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $2.5 Million - $2.84 Million
15,613 Added 158.15%
25,485 $4.64 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.36 Million - $1.53 Million
9,872 New
9,872 $1.53 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $3.51 Million - $4.44 Million
-32,700 Reduced 24.15%
102,727 $13.9 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $885,992 - $1.01 Million
-8,327 Reduced 5.79%
135,427 $14.6 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $781,499 - $870,635
7,428 Added 5.45%
143,754 $16.2 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $2.46 Million - $2.71 Million
24,061 Added 21.43%
136,326 $14.8 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $1.52 Million - $2.06 Million
-18,940 Reduced 14.44%
112,265 $12 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $3.75 Million - $4.4 Million
43,648 Added 49.85%
131,205 $11.5 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $1.39 Million - $1.86 Million
18,932 Added 27.59%
87,557 $8.6 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $798,187 - $1.21 Million
-12,375 Reduced 15.28%
68,625 $5.23 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $5.84 Million - $7.31 Million
81,000 New
81,000 $7.17 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.